HPLC System Suitability for Peptides: Checks Before a Sample Runs
Before a testing lab reports a purity result, it has to show that the instrument was fit to produce one. HPLC system suitability for peptides is the name for that proof: a short set of injections and pass/fail criteria run at the start of an analytical sequence, and often repeated through it. If the system fails, the samples are not reported. For QC and procurement teams receiving large research orders, knowing what these checks cover helps explain why two certificates for the same material can disagree, and what a purity figure is quietly relying on.
Why a working instrument needs proving each day
An HPLC can look perfectly normal and still be drifting out of control. A column slowly loses efficiency. A pump seal starts to leak. The mobile phase is mixed slightly differently from last week. None of this is obvious from a single sample chromatogram, because a degraded system and an impure sample can produce traces that look much the same.
System suitability separates those two explanations. The lab injects a reference solution (often the target peptide itself, sometimes a mixture containing a known close impurity) and checks the result against limits written into the method. Only once the system passes are unknown samples interpreted.
HPLC system suitability for peptides: the core parameters
Methods vary, but most include some combination of the following. The limits in the right-hand column are commonly used starting points, not universal rules; each method sets its own.
| Parameter | What it shows | Typical style of limit |
|---|---|---|
| Injection precision | Replicate injections give consistent peak areas | Relative standard deviation at or below about 2% across five or six injections |
| Retention time consistency | Pump, temperature and mobile phase are stable | Small percentage variation between injections |
| Tailing factor | Peak symmetry, so neighbours are not swallowed | Often no more than about 2 |
| Plate count | Column efficiency, which controls peak width | A minimum set for the specific column and method |
| Resolution of a critical pair | The hardest-to-separate species really are separated | Commonly 1.5 to 2.0 or higher |
The critical pair
Resolution is the parameter most directly tied to purity. Method developers identify the impurity that sits closest to the main peak, often a deletion sequence or a deamidated form, and require the system to separate it from the target each time. If the critical pair merges on the day, every sample run that day may be hiding the same impurity under its main peak.
Blanks and carryover
Many sequences also include a blank injection of solvent. Its job is to show that nothing from a previous run is bleeding into the next. A peak in the blank at the retention time of the target points to carryover, which would inflate or distort the following result.
How a failing system shifts the purity figure
Purity is the main peak’s share of total peak area. Each system suitability parameter touches that ratio in a predictable way:
- Lost plates: broader peaks overlap more, and small impurities disappear into the main peak. Purity tends to read high.
- Tailing: a smeared main peak covers later-eluting impurities, and integration has to guess where boundaries lie.
- Poor precision: peak areas scatter, so the same vial analysed twice may return noticeably different figures.
- Shifting retention: peaks drift away from their expected windows, making identity assignment less certain.
The consequence is counter-intuitive: a worn column can make a sample look purer than it would on a healthy one. That is exactly why labs are expected to prove the system before trusting it.
Long sequences and many lots
When a laboratory runs a large batch, for example several lots or dozens of vials from one bulk order, a single check at the start is not always enough. Good practice is to bracket samples with further standard injections through the sequence and at the end. If the late standards drift out of limits, samples run after the last passing standard are re-analysed.
For a buyer, this matters when you compare lots that were tested weeks or months apart. Consistency across lots is only meaningful if each lot’s result came from a system that passed its checks on the day.
Reading suitability data if you receive it
Most certificates issued for research peptides do not show system suitability data. That is ordinary rather than alarming; the checks usually live in the laboratory’s internal records. If you do receive them, or can ask for them on a large order, two questions are most useful:
- Were the acceptance criteria stated alongside the results?
- Did the results pass comfortably, or sit right at the edge of the limits?
A laboratory accredited to ISO/IEC 17025 will normally have system suitability built into its validated methods even when the customer copy leaves it out. For your own records, note the testing lab and method reference with each lot, so that a sudden change in reported purity can be checked against a change in lab or method first.
Bulk Peptides products are sent for third-party HPLC and purity testing. A selection of certificates is published, and cap and crimp colour on each vial links it to the relevant certificate, which helps when a receipt covers several lots.
The limits of system suitability
Passing system suitability means the instrument and method were performing as designed that day. It does not show that the method was the right one for the compound, that the wavelength suits the sequence, that the sample was representative of the lot, or anything about sterility and endotoxin. A precisely controlled measurement of the wrong property is still the wrong measurement.
Bulk Peptides sells research compounds for laboratory and in-vitro study only. They are not for use in humans or animals.
